Advertisement · 728 × 90

Posts by Torsten Joerger

Identified needs in antimicrobial stewardship education for pediatric advanced practice providers: a qualitative analysis View abstract Introduction:There is limited research investigating advanced practice provider (APP) knowledge and perspectives on education in antimicrobial stewardship (AS).Setting:Large academic children’s hospital.Participants:APPs in Division of Pediatrics, Antimicrobial Stewardship Program (ASP) stakeholders.Objective design:We conducted four focus groups with APPs and one focus group with ASP stakeholders. APPs were asked eleven open questions about training, influences on prescribing practices, knowledge gaps and desired topics for education in AS as well as general barriers to learning. ASP stakeholders were asked five open-ended questions about teaching initiatives, knowledge gaps and high yield teaching topics for APPs.Results:20 APPs and 6 ASP stakeholders (1 medical director, 3 pharmacists and 2 pediatric infectious diseases fellows) participated in focus groups. Four domains and eight themes were generated. (1) Barriers to AS in Practice: lack of critical thinking and conflict between the ASP and APPs within the cultural context of the institution. (2) Approach to Education: logistical challenges to curriculum development and adopting APP centered approaches to teaching. (3) Education for New to Practice APPs: learning basics of microbiology, infectious diseases and utilizing resources to encourage AS in practice. (4) Education for Experienced APPs: learning approaches to common clinical scenarios and updates to improve AS in practice.Conclusions:Curricular content should acknowledge the cultural influences of the institution, target knowledge gaps and areas of interest of learners, and be delivered via flexible and engaging learning modalities that encourage maximal participation.

Study at large children's hospital surveyed 20 APPs & 6 ASP stakeholders. Found barriers: lack of critical thinking, cultural conflicts. Education needs basics for newbies & updates for experts.📚

#idsky

3 months ago 1 1 0 0

No idea. I don’t fault the ref but surely VAR should see that and call it out. Looks to be a bad injury at a position we’ve struggled in all season, wonder if they’ll have to find another rb.

In positive news, how nice was it to see the whole team give it their all for a full 90?

3 months ago 3 0 0 0

Honestly thought it should be straight red for throwing an injured player.

3 months ago 2 0 0 0

These games are so bad for my heart

4 months ago 0 0 0 0

Really great video

8 months ago 2 0 0 0
Preview
Static vs. cidal: it’s not complex; it’s simply incorrect | Antimicrobial Agents and Chemotherapy In the first sentence of their recent study (1), Gil-Gil and Berryhill cite a 2018 review article (2) to support the statement, “The clinical outcomes of antibiotic treatments involving the administra...

We implore authors, peer reviewers,and journal editors to stop perpetuating the concept of static and cidal antibiotics, given the aforementioned evidence demonstrating it is a myth. In a clinical context, these terms are not complex. Rather,they are simply incorrect
journals.asm.org/doi/10.1128/...

9 months ago 26 9 1 4
Disparities in Nirsevimab Uptake Across a Pediatric Primary Care Network 10.1542/6372579447112Video AbstractPEDS-VA_2025-0707906372579447112OBJECTIVE. Nirsevimab, a monoclonal antibody for respiratory syncytial virus (RSV) prophylaxis, debuted during the 2023–2024 RSV seas...

publications.aap.org/pediatrics/a...

9 months ago 3 0 0 0

Proud to be part of this work lead by wonderful medical student Mahaa Ahmed examining the roll out of nirsevimab in its first season of use. This study examined children born outside of RSV season who are therefore dependent on their primary care practices (and not birth hospital) to get nirsevimab

9 months ago 5 1 1 0
Advertisement

Doesn’t seem to be available to purchase

9 months ago 2 0 1 0

I’ve also had good luck with it which is interesting because I never learned about it in training

9 months ago 2 0 0 0

Do you know where I can purchase a copy of this book?

9 months ago 1 0 2 0

Congrdulations!

9 months ago 1 0 1 0

Thanks! That’s cool they can get the half life that long

9 months ago 0 0 0 0

Interesting? Any idea of the mechanism of action?

9 months ago 0 0 1 0

I don’t believe the Mach E, which is pictured here and a great car, is eligible for the tax credit

9 months ago 0 0 0 0
Dr. Audrey Odom John

Dr. Audrey Odom John

With funding from the Gates Foundation, CHOP's Infectious Diseases Chief Dr. Audrey Odom John + team are advancing the development of a 'malaria breathalyzer' to detect the malaria-causing parasite in asymptomatic patients & reduce transmission. Learn more: http://ms.spr.ly/63325SxyBS

9 months ago 5 2 0 0
Post image

The death toll this past #flu season took on kids continues to climb. In its latest flu update, #CDC reports on another 4 deaths, bringing the total to date to 250 — an extraordinary number. 89% of the kids for whom vaccination status was known weren't fully vaccinated.
www.cdc.gov/fluview/surv...

10 months ago 83 35 4 4
Advertisement

You should consider publishing a summary of this work. Important to get this review out in the literature to people beyond the bluesky world

10 months ago 2 0 1 0

Don’t remember last time I used combination therapy or IV therapy for more than a few days in any bone or joint infection no matter the complexity of patient

10 months ago 1 0 1 0
Post image

ACOG is deeply disappointed by HHS’s move to drop COVID-19 vaccine recommendations in pregnancy. The science is clear: COVID-19 remains dangerous in pregnancy and vaccination protects both patients and newborns. The vaccine is safe and protects families. Read our full statement: buff.ly/OGue7sO

10 months ago 525 336 13 25

Does anyone know how often MSSA falls into each of these mic categories? Our lab doesn’t report MIC for cefazolin for MSSA

11 months ago 1 0 1 0
Post image

#RSV rates in infants are falling. Hospitalizations are down 28 % and 43 % for infants less than 7 months in two different networks, as reported in this week's MMWR.

This is real world evidence that maternal immunization and MAbs are protecting this vulnerable populations - #MedSky.

11 months ago 152 43 3 12

Interesting. I’ll look forward to reading your paper.

11 months ago 1 0 0 0

Where do most ecmo related infections come from?

11 months ago 1 0 1 0
Vaccine RCTs | mysite

Placebo trials of vaccines; it's amazing what you find when you look! @jakescottmd.bsky.social @abhaydhand.bsky.social @alejodiaz81.bsky.social
Thus far, 94 RCTs of vaccines identified. Among them, 69 placebo controlled, & 4 control groups received nothing. So...
www.bradspellberg.com/vaccine-rcts

11 months ago 26 10 4 0
Post image
11 months ago 7 4 0 0
Advertisement
Post image

Clinicians often don't adhere to pediatric Tamiflu guidelines, analysis finds

Among clinicians with knowledge of guidelines, 62.0% recommended use.

www.cidrap.umn.edu/i...

11 months ago 8 7 0 0
Variability of Clinician Recommendations for Oseltamivir in Children Hospitalized With Influenza 10.1542/6365852073112Video AbstractPEDS-VA_2024-0691116365852073112BACKGROUND AND OBJECTIVES. Although national recommendations advise antivirals for all hospitalized children with influenza, this rec...

When presented with vignettes of children hospitalized with influenza, many clinicians did not recommend use of oseltamivir despite guideline recommendations. Does this suggest a need for rcts in hospitalized children? More
education? Different guidelines?

publications.aap.org/pediatrics/a...

11 months ago 1 0 0 0
Preview
$5 million boost for world-first trial tackling strep infections in both children and adults A major new clinical trial, the Streptococcal Adaptive Platform (STRAP), has received $5 million in funding from the Australian Government’s Medical Research Future Fund (MRFF) to improve treatment for life-threatening streptococcal infections across all age groups. Lead by researchers and clinicians from the Doherty Institute, Murdoch Children's Research Institute (MCRI), and other national and international partners.

SNAP is extending from S aureus to invasive streptococcal infections!

A new platform trial for iGAS and iSDSE

@gurujosh.bsky.social @joshosowicki.bsky.social @drmichaelmarks.bsky.social

www.doherty.edu.au/news-events/...

1 year ago 42 14 1 3
Post image

@steventong.bsky.social @gurujosh.bsky.social presenting results of the MSSA domain of the SNAP 🫰 trial at #ESCMID2025. just amazing work by amazing humans - congratulations on this practice changing effort!! #idsky #medsky #amssky

1 year ago 28 6 4 1